Literature DB >> 12729599

Filter binding assay for the geldanamycin-heat shock protein 90 interaction.

Christopher W Carreras1, Andreas Schirmer, Ziyang Zhong, Daniel V Santi.   

Abstract

A filter binding assay to measure affinity of [3H-allyl]17-allylamino geldanamycin ([3H]AAG) for the ATP binding site of the N-terminal domain of human Hsp90alpha (hHsp90alpha9-236) was developed. Diethylaminoethyl cellulose or glass fiber filters impregnated with polyethyleneimine were used to capture the [3H]AAG-Hsp90 complex, and conditions which washed >98% of free [3H]AAG from the filters were developed. The complex formed at a rapid rate (k(on)=2.5 x 10(7)Lmol(-1) x s(-1)) and dissociated with a half-life of 2.3 min (k(off)=5 x 10(-3) x s(-1)). hHsp90alpha9-236 bound to [3H]AAG with a K(d) value of 0.4+/-0.1 microM. [3H]AAG had similar affinities for full-length hHsp90alpha and for hHsp90alpha9-236 variants containing biotinylated N-terminal biotinylation signal sequences and N- or C-terminal His(6) tags. Geldanamycin, ADP, ATP, and radicicol-all known to bind to the ATP domain of Hsp90-competed with [3H]AAG for binding to hHsp90alpha9-236, showing K(d) values in good agreement with reported values.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729599     DOI: 10.1016/s0003-2697(03)00060-5

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion.

Authors:  Qian Xie; Robert Wondergem; Yuehai Shen; Greg Cavey; Jiyuan Ke; Ryan Thompson; Robert Bradley; Jennifer Daugherty-Holtrop; Jennifer Daughtery-Holtrop; Yong Xu; Edwin Chen; Hanan Omar; Neal Rosen; David Wenkert; H Eric Xu; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

2.  Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo.

Authors:  Bonnie Tillotson; Kelly Slocum; John Coco; Nigel Whitebread; Brian Thomas; Kip A West; John MacDougall; Jie Ge; Janid A Ali; Vito J Palombella; Emmanuel Normant; Julian Adams; Christian C Fritz
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

3.  HSP90 Inhibition and Cellular Stress Elicits Phenotypic Plasticity in Hematopoietic Differentiation.

Authors:  Abdalla A Lawag; Jennifer M Napper; Caroline A Hunter; Nickolas A Bacon; Seth Deskins; Manaf El-Hamdani; Sarah-Leigh Govender; Emine C Koc; Vincent E Sollars
Journal:  Cell Reprogram       Date:  2017-09-14       Impact factor: 1.987

4.  Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy.

Authors:  Xin Pan; Teng-Yu Mao; Yan-Wen Mai; Cheng-Cheng Liang; Wei-Hao Huang; Yong Rao; Zhi-Shu Huang; Shi-Liang Huang
Journal:  Molecules       Date:  2022-08-29       Impact factor: 4.927

5.  Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design.

Authors:  Arun Chandramohan; Srinath Krishnamurthy; Andreas Larsson; Paer Nordlund; Anna Jansson; Ganesh S Anand
Journal:  PLoS Comput Biol       Date:  2016-06-02       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.